WO2025006830A3 - Compounds for the treatment of retinitis pigmentosa and methods of making and using the same - Google Patents

Compounds for the treatment of retinitis pigmentosa and methods of making and using the same Download PDF

Info

Publication number
WO2025006830A3
WO2025006830A3 PCT/US2024/035948 US2024035948W WO2025006830A3 WO 2025006830 A3 WO2025006830 A3 WO 2025006830A3 US 2024035948 W US2024035948 W US 2024035948W WO 2025006830 A3 WO2025006830 A3 WO 2025006830A3
Authority
WO
WIPO (PCT)
Prior art keywords
same
methods
compounds
making
retinitis pigmentosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2024/035948
Other languages
French (fr)
Other versions
WO2025006830A2 (en
Inventor
Sudeshna ROY
Mario DJUGOVSKI
Tzu-Yu Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Mississippi
Original Assignee
University of Mississippi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Mississippi filed Critical University of Mississippi
Publication of WO2025006830A2 publication Critical patent/WO2025006830A2/en
Publication of WO2025006830A3 publication Critical patent/WO2025006830A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

In one aspect, the disclosure relates to substituted N-acetylated cysteine- and selenocysteine-based compounds. Also disclosed are methods of making the same, pharmaceutical compositions comprising the same, and methods of treating eye disorders including retinitis pigmentosa (RP) using the same. In some aspects, the compounds can also have antimicrobial activity. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
PCT/US2024/035948 2023-06-28 2024-06-28 Compounds for the treatment of retinitis pigmentosa and methods of making and using the same Ceased WO2025006830A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363510709P 2023-06-28 2023-06-28
US63/510,709 2023-06-28

Publications (2)

Publication Number Publication Date
WO2025006830A2 WO2025006830A2 (en) 2025-01-02
WO2025006830A3 true WO2025006830A3 (en) 2025-04-24

Family

ID=93940011

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/035948 Ceased WO2025006830A2 (en) 2023-06-28 2024-06-28 Compounds for the treatment of retinitis pigmentosa and methods of making and using the same

Country Status (1)

Country Link
WO (1) WO2025006830A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018216823A1 (en) * 2017-05-25 2018-11-29 Taisho Pharmaceutical Co., Ltd. Alpha-amino amide derivatives
US11173135B2 (en) * 2016-03-17 2021-11-16 Thiogenesis Therapeutics, Inc. Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11173135B2 (en) * 2016-03-17 2021-11-16 Thiogenesis Therapeutics, Inc. Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
WO2018216823A1 (en) * 2017-05-25 2018-11-29 Taisho Pharmaceutical Co., Ltd. Alpha-amino amide derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE PubChem 6 December 2019 (2019-12-06), "SID 388891440", XP093307634, Database accession no. SID 388891440 *

Also Published As

Publication number Publication date
WO2025006830A2 (en) 2025-01-02

Similar Documents

Publication Publication Date Title
MX2025012306A (en) 2-azabicyclo[2.2.1]heptane kras inhibitors
NZ539841A (en) Hydroxyethylamine derivatives for the treatment of alzheimer's disease
WO2024189598A3 (en) Acylsulfonamide kat6a inhibitors
WO2024006726A3 (en) Compounds as inhibitors of axl
MX2022015022A (en) Pralsetinib pharmaceutical compositions.
CA2148194A1 (en) Cyclopeptides of the formula i
UA86614C2 (en) Compound having kinase ingibitor activity, pharmaceutical composition containing thereof and use thereof for the preparation of medicine
WO2023122783A8 (en) Tetrahydropyrazolopyrimidines and related analogs for inhibiting yap/taz-tead
GEAP202516737A (en) Compounds for treating cancer
MX2023009166A (en) Quinoxaline derivatives and uses thereof.
WO2022020114A3 (en) Methods for the prevention and treatment of hearing loss
WO2023150790A3 (en) Novel and highly selective sars-cov-2 mpro inhibitors
MX2025006291A (en) Methods of treating neurological disorders
WO2025006726A3 (en) Tmem175 agonists, compositions, and methods of use
MX2024014831A (en) Sialic acid derivatives and methods of using same
WO2023164175A3 (en) Protacs of malt1
CN107519102A (en) A kind of antibacterial hair tonic light-coloured vinegar shampoo
WO2023215803A3 (en) Cytochrome bd oxidase inhibitors and uses thereof
MX2025009410A (en) Crystalline forms or salts of a deuterated compound
WO2024019978A3 (en) Therapeutic combinations and methods
WO2024115797A3 (en) Dihydro-quinazoline, -benzothiazine and -benzoxazine derivatives and use thereof as orexin receptors agonists for treating or preventing neurological diseases
WO2023150702A3 (en) Compositions and methods for treatment of connective tissue disorders
HUE024108T2 (en) An agricultural composition, method for the production thereof and uses in the treatment of cultures
WO2022200553A3 (en) Immune stimulating nanoparticle composition
MX2023005031A (en) Degradant compound in a medicament.

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 24832976

Country of ref document: EP

Kind code of ref document: A2